AMANDA HUTSON: Open Payments
NPI 1184012098 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 40 payments from 16 companies in 2025. Trend: 2023 $400 · 2024 $1,011 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $273 |
| Janssen Biotech, Inc. | 6 | $142 |
| Breas Medical, Inc. | 1 | $93 |
| Madrigal Pharmaceuticals | 1 | $48 |
| Ardelyx, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Mauna Kea Technologies, Inc. | 1 | $24 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Vivo 45 LS, REZDIFFRA, IBSRELA, DUPIXENT, OMVOH.
Industry payments across TN — which companies pay providers there.
